Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria

Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds Thiazolidinone/thiazole based hybrids – New class of antitrypanosomal agents Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: Structural design, synthesis and pharmacological evaluation Development of second generation amidinohydrazones, thio- and semicarbazones as Trypanosoma cruzi-inhibitors bearing benzofuroxan and benzimidazole 1,3-dioxide core scaffolds Design, synthesis and biological evaluation of new aryl thiosemicarbazone as antichagasic candidates In vitro antiparasitic activity of new thiosemicarbazones in strains of Trypanosoma cruzi Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes